Zobrazeno 1 - 10
of 21
pro vyhledávání: '"11"'
Autor:
Victor H. Rodrigues, Flavio C. Moore, Rodrigo C. Guimaraes, Charles A. J. Padua, Andre M. Murad, Bruno C. Aragao, Antonio O. Scalabrini-Neto
Publikováno v:
American Journal of Clinical Oncology. 26:151-154
In this phase II trial, we used the combination of gemcitabine and 5-fluorouracil (5-FU) to treat 26 patients: 17 (65%) with advanced pancreatic adenocarcinoma and 9 (35%) with advanced biliary tract adenocarcinoma (10 locally advanced and 16 metasta
Autor:
Steven Lunzer, Robert G. Wadleigh, Steven H. Krasnow, Eugene B. Davis, Mohammed A. Hussain, Daya Sharma
Publikováno v:
American journal of clinical oncology. 20(2)
A Phase II study of sequential chemotherapy with 5-fluorouracil and cisplatin followed by radiotherapy was initiated to see whether the use of two therapies sequentially could have an effect on response rate. Thirteen patients with advanced squamous
Publikováno v:
American Journal of Clinical Oncology. 26:174-177
We evaluated the efficacy and toxicity of gemcitabine with or without cisplatin in 11 chemonaive patients with histologically confirmed advanced gallbladder cancer. All were symptomatic and had stage IV disease. Eight patients received gemcitabine 1
Autor:
Oscar Abuchaibe, O. F. Hidalgo, Fernando Pardo, E. Tangco, J. M. Vieitez, Joseba Rebollo, I. Bilbao
Publikováno v:
American Journal of Clinical Oncology. 16:30-33
Thirty-one patients with hepatic metastases from colorectal carcinoma were treated with carboplatin (CBDCA), 55 mg/m2, given in a 4-hour intra-arterial infusion daily for 5 days, and 5-fluorouracil, 900 mg/m2, given in a 20-hour intra-arterial infusi
Autor:
Harry E. Hynes, Conrad H. Gumbart, Robert W. Veith, Donna H. Ryan, Richard H. Vial, David R. Head, Kenneth J. Kopecky, David A. Lipschitz, Michael R. Grever, Stephen M. Shiaer
Publikováno v:
American Journal of Clinical Oncology. 15:69-75
Fourteen participating centers registered 33 patients on a Southwest Oncology Group Study of adults with acute non-lymphocytic leukemia (ANLL). Induction consisted of cytosine arabinoside 70 mg/m2 days 1-7 by continuous intravenous (i.v.) infusion, V
Autor:
Paolo Alberto Paciucci, R. Odchimar, P. A. Chahinian, J. S. Ryder, J. G. Bekesi, James F. Holland
Publikováno v:
American Journal of Clinical Oncology. 14:341-348
Twelve women and 7 men, median age 58 (range 17-74), with a diagnosis of non-small-cell lung cancer (11 patients), inflammatory breast cancer (5 patients), osteosarcoma (2 patients), and colon carcinoma (1 patient) were studied. Treatment consisted o
Autor:
Alexandra M. Levine, Parkash S. Gill, Mark U. Rarick, Vinay Shaw, Maria Harb, Marjorie Bernstein-Singer, Byron M. Espina
Publikováno v:
American Journal of Clinical Oncology. 13:315-319
Eighteen patients with disseminated AIDS-related Kaposi's sarcoma (KS) and compromised bone marrow function were treated with a relatively non-myelosuppressive regimen of bleomycin and vincristine (BV). At study entry, the patients presented with the
Publikováno v:
American Journal of Clinical Oncology. 13:167-170
The effects on hematological parameters in peripheral blood was measured by electronic cell counting after electrochemical treatment (n = 11), after electrochemical treatment with concomitant intraneoplastic injection of the chemotherapeutic agent do
Publikováno v:
American Journal of Clinical Oncology. 19:229-231
A 42-year-old woman with liver metastasis from adrenal cortical carcinoma was treated with mitotane (o,p'DDD) for 11 months with a minimal response. Mitotane was stopped because of severe adverse effects. Thereafter a combination of cisplatin and eto
Autor:
Thomas King, Daniel Quirk, Robert Mass, Shamlal Mangray, Todd M. Moore, Howard Safran, Margaret M. Steinhoff, Umadevi Tantravahi, Ritesh Rathore, Terese Pasquariello, Katya Berzein, David A. Iannitti, Paul A. Akerman, Philip T. Reiss, Li Chai, Lisa Goldstein
Publikováno v:
American journal of clinical oncology. 24(5)
Novel systemic treatments are needed in pancreatic cancer. The authors sought to establish the frequency of overexpression of the HER-2/neu oncogene in patients with pancreatic adenocarcinoma to determine the potential role of trastuzumab (Herceptin)